Latest Report Available at Orbis research Sickle Cell
Market provides pin-point analysis for changing competitive dynamics and a
forward looking perspective on different factors driving or restraining
industry growth.
Request sample
copy of this report at Sickle Cell Market Research Report
Sickle Cell (SC) is a genetic blood disorder caused by inheriting
abnormal hemoglobin (Hb) genes from parents. Normally, red blood cells (RBC)
have disc-like shapes which help them to travel throughout the blood vessels.
But in the case of SC, red blood cells of a person’s blood take an abnormal
sickle-like shape. Due to SC, red blood cells become sticky and inelastic.
These RBCs block the blood circulation in different parts of body by getting
blocked in the small blood vessels. Red blood cells live for about 120 days but
these sickle cells live for only 10-20 days. There are various types of sickle
cell disorders caused by different mutations in hemoglobin genes. Although, all
types of sickle cell disorder have similar symptoms but they differ in their
severity and nature of occurrence.
Currently, sickle cell is affecting approximately 20 to 25 million
people worldwide and approximately 300 thousand births occur with sickle cell
annually. Sickle cell has a high concentration rate in malaria endemic parts of
worlds, especially, African, Middle Eastern and South Asian regions. In many
African countries, 10% to 40% population carries sickle cell traits.
The U.S. is expected to be the first region to start the selling of
sickle cell drugs due to developing drug therapies and later on, market
penetration of sickle cell drugs would occur in Europe.
The global sickle cell market is expected to grow in future due to
rising African-American population, economic growth, increasing healthcare
expenditure and prevalence of sickle cell. Key trends of this market include
progressing drug pipeline and rising research grants. However, there are some
factors which can hinder growth of the market including regulatory changes,
associated risks and slow adoption of treatments.
The report “Global Sickle Cell Market: Industry Analysis & Outlook
(2020-2030)” by Koncept Analytics provides an extensive research and detailed
analysis of the present market along with future outlook. The report discusses
the major growth drivers and challenges of the market, covering the U.S, and
Europe along with the global market. The report profiles key players of the
market including Novartis, Bristol-Myers Squibb, Shire Plc, Bluebird Bio and
Global Blood Therapeutics Inc.
Browse
Complete Report @ http://www.orbisresearch.com/reports/index/global-sickle-cell-market-industry-analysis-and-outlook-2020-2030 .
Some points from TOC:
1. Overview
1.1 Sickle Cell
1.2 Types of Sickle Cell
1.3 Symptoms & Diagnosis
1.4 Treatment
1.1 Sickle Cell
1.2 Types of Sickle Cell
1.3 Symptoms & Diagnosis
1.4 Treatment
2. Global Market
2.1 Global Sickle Cell Drug Market Forecast by Value
2.2 Sickle Cell Drug Market by Region
2.1 Global Sickle Cell Drug Market Forecast by Value
2.2 Sickle Cell Drug Market by Region
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Sickle Cell Drug Market Forecast by Value
3.1.2 The U.S. Sickle Cell Patient Volume Forecast
3.1.3 The U.S. Sickle Cell Treated Patient Volume Forecast
3.1.4 The U.S. Sickle Cell Market Forecast by Treatment Cost
3.2 Europe
3.2.1 Europe Sickle Cell Drug Market Forecast by Value
3.2.2 Europe Sickle Cell Patient Volume Forecast
3.2.3 Europe Sickle Cell Treated Patient Volume Forecast
3.2.4 Europe Sickle Cell Market Forecast by Treatment Cost
3.1 The U.S.
3.1.1 The U.S. Sickle Cell Drug Market Forecast by Value
3.1.2 The U.S. Sickle Cell Patient Volume Forecast
3.1.3 The U.S. Sickle Cell Treated Patient Volume Forecast
3.1.4 The U.S. Sickle Cell Market Forecast by Treatment Cost
3.2 Europe
3.2.1 Europe Sickle Cell Drug Market Forecast by Value
3.2.2 Europe Sickle Cell Patient Volume Forecast
3.2.3 Europe Sickle Cell Treated Patient Volume Forecast
3.2.4 Europe Sickle Cell Market Forecast by Treatment Cost
Purchase a copy of Sickle Cell Market visit @ http://www.orbisresearch.com/contact/purchase/367141
For more information contact sales@orbisresearch.com .
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising American-African Population
4.1.2 Rising Economic Growth
4.1.3 Increasing Healthcare Expenditure
4.1.4 Increasing Prevalence of Sickle Cell
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
4.2.2 Rising Research Grants
4.3 Challenges
4.3.1 Regulatory Challenges
4.3.2 Associated Risks
4.3.3 Slow Adoption of Treatment
4.1 Growth Drivers
4.1.1 Rising American-African Population
4.1.2 Rising Economic Growth
4.1.3 Increasing Healthcare Expenditure
4.1.4 Increasing Prevalence of Sickle Cell
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
4.2.2 Rising Research Grants
4.3 Challenges
4.3.1 Regulatory Challenges
4.3.2 Associated Risks
4.3.3 Slow Adoption of Treatment
5. Competition
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players (2016)
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players (2016)
6. Company Profiles
6.1 Novartis
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Bristol-Myers Squibb
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Shire Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Bluebird Bio
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Global Blood Therapeutics Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
6.1 Novartis
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Bristol-Myers Squibb
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Shire Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Bluebird Bio
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Global Blood Therapeutics Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
For any enquires before buying, connect
with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter:
https://twitter.com/orbisresearch
Like us on Facebook:
https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment